Grimm R H, Leon A S, Hunninghake D B, Lenz K, Hannan P, Blackburn H
Ann Intern Med. 1981 Jan;94(1):7-11. doi: 10.7326/0003-4819-94-1-7.
A blood lipid-lipoprotein elevating effect of the diuretics hydrochlorothiazide and chlorthalidone in mildly hypertensive men has been established by a cross-over, randomized controlled trial, confirming previous clinical observations. Compared to baseline, plasma total cholesterol increased 6% and 8% and triglycerides 17% and 15% under treatment with hydrochlorothiazide and chlorthalidone, respectively. A cholesterol-lowering diet largely prevents this increase. Because these effects may be long-lasting and may cancel part of the potential benefit of blood pressure control in mildly hypertensive patients, with thiazide diuretics attention should be given to prescription of a cholesterol-lowering diet and to periodic monitoring of blood lipid levels. Different antihypertensive agents might be considered in patients with elevated blood lipid levels. Other antihypertensive agents currently in use need to be studied for potential effects on lipid metabolism.
一项交叉随机对照试验证实了利尿剂氢氯噻嗪和氯噻酮对轻度高血压男性患者有血脂-脂蛋白升高作用,这也证实了先前的临床观察结果。与基线相比,使用氢氯噻嗪和氯噻酮治疗时,血浆总胆固醇分别升高了6%和8%,甘油三酯分别升高了17%和15%。降胆固醇饮食在很大程度上可预防这种升高。由于这些影响可能是长期的,可能会抵消轻度高血压患者血压控制的部分潜在益处,因此使用噻嗪类利尿剂时应注意开具降胆固醇饮食处方并定期监测血脂水平。对于血脂升高的患者,可考虑使用不同的抗高血压药物。目前正在使用的其他抗高血压药物需要研究其对脂质代谢的潜在影响。